Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1061 | 953 | 1182 | 1130 | 1563 | 2243 |
Fund Return | 6.13% | -4.73% | 18.18% | 4.16% | 9.34% | 8.41% |
Place in category | 125 | 164 | 148 | 31 | 57 | 50 |
% in Category | 60 | 86 | 81 | 15 | 32 | 42 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Stock Market Ins Pls | 703.38B | 19.69 | 7.49 | - | ||
Vanguard 500 Index Admiral | 546.41B | 20.93 | 9.04 | 12.96 | ||
Vanguard Total Stock Market Admiral | 396.4B | 19.67 | 7.47 | 12.38 | ||
Vanguard Total Intl Stock Index Inv | 204.36B | 8.15 | 1.40 | 4.88 | ||
Vanguard 500 Index Institutional Se | 191.38B | 20.96 | 9.07 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Select Health Care | 10.35B | 9.86 | -0.54 | 9.10 | ||
T. Rowe Price Health Sciences | 8.46B | 8.60 | -1.25 | 9.86 | ||
Vanguard Health Care Inv | 6.94B | 6.09 | 4.10 | 8.36 | ||
Fidelity Advisor Health Care A | 6.23B | 8.57 | -1.13 | 8.24 | ||
Fidelity Advisor Health Care C | 6.23B | 7.87 | -1.88 | 7.43 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.57 | 753.41 | +3.25% | |
UnitedHealth | US91324P1021 | 7.62 | 600.50 | +4.07% | |
AstraZeneca | GB0009895292 | 5.64 | 10,007.6 | +0.39% | |
Merck&Co | US58933Y1055 | 4.49 | 97.44 | +0.93% | |
Novo Nordisk B | DK0062498333 | 3.90 | 726.1 | -1.63% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review